Truvestments Capital’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.75K | Hold |
756
| – | – | ﹤0.01% | 802 |
|
2025
Q1 | $1.45K | Hold |
756
| – | – | ﹤0.01% | 903 |
|
2024
Q4 | $1.44K | Hold |
756
| – | – | ﹤0.01% | 886 |
|
2024
Q3 | $998 | Buy |
+756
| New | +$998 | ﹤0.01% | 853 |
|
2024
Q2 | – | Sell |
-756
| Closed | -$1.38K | – | 236 |
|
2024
Q1 | $1.38K | Hold |
756
| – | – | ﹤0.01% | 634 |
|
2023
Q4 | $937 | Hold |
756
| – | – | ﹤0.01% | 713 |
|
2023
Q3 | $862 | Hold |
756
| – | – | ﹤0.01% | 628 |
|
2023
Q2 | $692 | Hold |
756
| – | – | ﹤0.01% | 648 |
|
2023
Q1 | $424 | Hold |
756
| – | – | ﹤0.01% | 637 |
|
2022
Q4 | $436 | Hold |
756
| – | – | ﹤0.01% | 874 |
|
2022
Q3 | $0 | Sell |
756
-144
| -16% | – | ﹤0.01% | 619 |
|
2022
Q2 | $0 | Buy |
+900
| New | – | ﹤0.01% | 641 |
|
2022
Q1 | – | Sell |
-900
| Closed | -$2K | – | 192 |
|
2021
Q4 | $2K | Hold |
900
| – | – | ﹤0.01% | 542 |
|
2021
Q3 | $3K | Hold |
900
| – | – | ﹤0.01% | 496 |
|
2021
Q2 | $3K | Hold |
900
| – | – | ﹤0.01% | 502 |
|
2021
Q1 | $3K | Buy |
900
+405
| +82% | +$1.35K | ﹤0.01% | 561 |
|
2020
Q4 | $1K | Buy |
+495
| New | +$1K | ﹤0.01% | 578 |
|
2020
Q3 | – | Sell |
-495
| Closed | -$6K | – | 319 |
|
2020
Q2 | $6K | Buy |
+495
| New | +$6K | 0.01% | 442 |
|
2019
Q4 | – | Sell |
-861
| Closed | -$3K | – | 152 |
|
2019
Q3 | $3K | Sell |
861
-74
| -8% | -$258 | ﹤0.01% | 619 |
|
2019
Q2 | $5K | Hold |
935
| – | – | ﹤0.01% | 608 |
|
2019
Q1 | $8K | Buy |
+935
| New | +$8K | 0.01% | 533 |
|
2018
Q3 | $8K | Buy |
+960
| New | +$8K | ﹤0.01% | 672 |
|